Find Grants for School Districts

Find out if you qualify for verified grants for School Districts. Discover your eligibility and key funding details for School Districts from major foundations and government agencies.

 

$ 100 Trillion
Total Dollars Available

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

Deadline: October 8, 2027


Opportunity Number: PAR-25-248

Agency: National Institutes of Health

Open Date: November 21, 2024

Close Date: October 8, 2027

Status: Posted

CFDA Numbers: 93.393

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Deadline: November 18, 2027


Opportunity Number: RFA-DA-26-034

Agency: National Institutes of Health

Open Date: November 20, 2024

Close Date: November 18, 2027

Status: Posted

CFDA Numbers: 93.839, 93.837, 93.840, 93.855, 93.233, 93.279, 93.838

NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)

Deadline: October 14, 2027


Opportunity Number: PAR-25-135

Agency: National Institutes of Health

Open Date: November 20, 2024

Close Date: October 14, 2027

Status: Posted

CFDA Numbers: 93.398

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)

Deadline: November 19, 2026


Opportunity Number: PAR-25-052

Agency: National Institutes of Health

Open Date: November 20, 2024

Close Date: November 19, 2026

Status: Posted

CFDA Numbers: 93.853

Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2027


Opportunity Number: PAR-25-112

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.865, 93.173

Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)

Deadline: September 7, 2027


Opportunity Number: PAR-25-113

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.865, 93.173

Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-243

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.393

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

Deadline: November 16, 2027


Opportunity Number: PAR-25-244

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: November 16, 2027

Status: Posted

CFDA Numbers: 93.393

Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2026


Opportunity Number: PAR-25-038

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)

Deadline: September 7, 2026


Opportunity Number: PAR-25-037

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

Enhancing Reuse of NHGRI Data Assets (R03 Clinical Trial Not Allowed)

Deadline: February 15, 2026


Opportunity Number: RFA-HG-25-005

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: February 15, 2026

Status: Posted

CFDA Numbers: 93.172

Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2027


Opportunity Number: PAR-25-228

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.879, 93.172

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Deadline: September 7, 2027


Opportunity Number: PAR-25-229

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.172, 93.879

Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)

Deadline: May 7, 2026


Opportunity Number: PAR-25-176

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.351

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

Deadline: January 7, 2027


Opportunity Number: PAR-25-069

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.393

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2027


Opportunity Number: PAR-25-070

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.393

NCMRR Early Career Research Award (R03 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-124

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.865

NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)

Deadline: January 7, 2028


Opportunity Number: PA-25-126

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.865

NICHD Small Research Grant Program (R03 Clinical Trial Required)

Deadline: January 7, 2028


Opportunity Number: PA-25-125

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.865

NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)

Deadline: November 12, 2027


Opportunity Number: PAR-25-204

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: November 12, 2027

Status: Posted

CFDA Numbers: 93.279

NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)

Deadline: May 7, 2026


Opportunity Number: PAR-25-164

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.121

NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-105

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.121

NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)

Deadline: May 7, 2026


Opportunity Number: PAR-25-166

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.121

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-065

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242, 93.866

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-064

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.866, 93.242

×

Request Grant Writing Assistance from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.